6132-37-2

• 常用中文名：5-溴-2-呋喃甲酸乙酯
• 常用英文名：Ethyl 5-Bromo-2-furancarboxylate
• CAS号：6132-37-2
• 分子式：C₇H₇BrO₃
• 分子量：219.03300
• 发布时间：2018-04-20 08:00:00
• 更新时间：2025-08-20 17:14:00

名称

• 中文名: 5-溴-2-糠酸乙酯
• 英文名: ethyl 5-bromofuran-2-carboxylate
• 中文别名: 5-溴呋喃-2-羧酸乙酯
• 英文别名: 2-bromo-5-ethoxycarbonyl-furan; 5-bromo-furan-2-carboxylic acid ethyl ester; 2-bromo-5-(carbethoxy)furan; ethyl 5-bromo-2-furancarboxylate; ETHYL 5-BROMO-2-FUROATE

物化性质

• 密度: 1.533g/cm3
• 沸点: 243.2ºC at 760 mmHg
• 熔点: 17 °C
• 分子式: C₇H₇BrO₃
• 分子量: 219.03300
• 闪点: 100.9ºC
• 精确质量: 217.95800
• PSA: 39.44000
• LogP: 2.21880
• 外观性状: 液体;Colorless to Light orange to Yellow clear liquid
• 折射率: 1.509
• 储存条件: 室温，干燥

安全

• 海关编码: 2932190090

合成路线

585-70-6 64-17-5 ~93% 6132-37-2

文献：SCHERING CORPORATION; PHARMACOPEIA DRUG DISCOVERY, INC. Patent: WO2005/68460 A1, 2005 ; Location in patent: Page/Page column 314-315 ; WO 2005/068460 A1

1917-15-3 64-17-5 ~95% 6132-37-2

文献：Schering Corporation Patent: US2004/106794 A1, 2004 ; Location in patent: Page 127 ; US 20040106794 A1

64-17-5 ~94% 6132-37-2

文献：Schering Corporation and Pharmacopeia, Inc. Patent: US2004/147559 A1, 2004 ; Location in patent: Page 126 ; US 20040147559 A1

585-70-6 ~69% 6132-37-2

文献：ARROW THERAPEUTICS LIMITED Patent: WO2009/34390 A1, 2009 ; Location in patent: Page/Page column 26-27 ; WO 2009/034390 A1

585-70-6 75-03-6 ~% 6132-37-2

文献：EP1086950 A1, ;

26726-16-9 ~% 6132-37-2

文献：WO2004/33440 A1, ; Page 247; 345 ; WO 2004/033440 A1

26726-16-9 64-17-5 ~99% 6132-37-2

文献：Cella, James A. Journal of Organic Chemistry, 1988 , vol. 53, # 9 p. 2099 - 2103

88-14-2 ~% 6132-37-2

文献：Justus Liebigs Annalen der Chemie, , vol. 580, p. 169,187

75-03-6 ~% 6132-37-2

文献：Justus Liebigs Annalen der Chemie, , vol. 232, p. 86

上下游产品

上游产品  6
585-70-6 64-17-5 1917-15-3 75-03-6
26726-16-9 88-14-2
下游产品  7
89282-37-1 5965-53-7 3199-50-6 115102-47-1
90185-38-9 60336-07-4 5398-05-0

海关

海关编码	2932190090
中文概述	2932190090 其他结构上有非稠合呋喃环化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%